TLK286 L--Glutamyl-3-(bis[bis(2-chloroethyl)amino-phosphinyl]oxy)ethylsulfonyl-L-alanyl-2-phenyl-[2 R ]-glycine hydrochloride salt (TLK286) represents the most promising GST-prodrug candidate
Unveiling novel biomarkers: a clinical study of miR-146a and miR-222 in the diagnosis and treatment of polycystic ovary syndrome
Increasing healthcare access, growing patient awareness, and the adoption of advanced therapies are driving market penetration
10.1016/j.neurobiolaging.2016.09.005 Neurobiol
Sirtori CR, Calabresi L, Ferrara S, Pazzucconi F, Bondioli A, Baldassarre D, Birreci A, Koverech A: L-Carnitine reduces plasma lipoprotein(a) levels in patients with hyper Lp(a)
Weight re-gain following the cessation of GLP-1 RAs for weight management: a systematic review and meta-analysis.